Endovascular Treatment of TASCⅡC/D Aortoiliac Occlusive Disease by Covered Endovascular Reconstruction of Aortic Bifurcation
Objective To clarify the clinical efficacy of endovascular treatment of TASCⅡC/D aortoiliac occlusive disease(AIOD)using the covered endovascular reconstruction of aortic bifurcation(CERAB).Methods The clinical data of 23 AIOD patients admitted to the Department Ⅴ of Vascular Surgery of Xiangyang No.1 People′s Hospital from December 2019 to December 2022 were retrospectively analyzed.The surgical outcome and the follow-up results were discussed.Re-sults All patients successfully underwent the surgery,with a success rate of 100%.Seventeen patients received stent im-plantation in the first stage and 6 received stent implantation in the second stage after catheter-directed thrombolysis(CDT),with the average CDT time of(24.3±3.1)h,the average amount of urokinase being(83.1±16.7)U,the average surgical time of(95.7±20.1)min,and the average hospital stay being(6.5±1.9)d.Postoperatively,the ankle brachial index(ABI)showed an improvement compared with the preoperative value(P＜0.05).All 23 cases were followed up(100%)with a median follow-up time of(32.9±20.5)months.During the follow-up period,there were no cases of ampu-tation or death,with a limb salvage rate of 100%.The ABI at 3,6,and 12 months after operation was all higher than that before operation(P＜0.05).Conclusion CERAB has achieved satisfactory results and early to mid-stage patency in the treatment of TASCⅡC/D AIOD.
万方数据
维普
